23:06:19 Europe / Stockholm


2023-08-31 07:53:00

Since our last update, new readouts have been published with BI-1808 and BI-1206 in solid tumours. We review these results and the near-term outlook of the project portfolio. In particular, we expect news about the subcutaneous version of BI-1206 soon, which will be key to its future development.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/